ArticleBlood cancer journal2011

Virus reactivations and serology patterns following first-line therapy with alemtuzumab or fludarabine-based combination therapy in patients with chronic lymphocytic leukemia.

C Karlsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.